These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3792219)

  • 1. [Cytomorphological grading and hormone receptor status in breast carcinoma. Visual studies of smear preparations].
    Schenck U; Burger G; Jütting U; Eiermann W
    Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1949-53. PubMed ID: 3792219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
    Schenck U; Jütting U; Eiermann W
    Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Puncture cytology of the breast: correlation of visual and image analysis studies with hormone receptor status].
    Schenck U; Burger G; Jütting U; Peters-Welte C; Eiermann W
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):17-21. PubMed ID: 3845025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
    Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
    Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
    Szakacs JG; Arroyo JG; Girgenti AJ
    Ann Clin Lab Sci; 1986; 16(4):266-73. PubMed ID: 3740795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
    Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
    Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative determination with image analysis of immunohistochemically identified steroid hormone receptors in breast carcinoma].
    Mink D; Uhrmacher S; Heiss C; Villena-Heinsen C; Schmidt W
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):17-22. PubMed ID: 7705593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
    Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
    Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas.
    Vollmer G; Gerdes J; Knuppen R
    Cancer Res; 1989 Jul; 49(14):4011-4. PubMed ID: 2736540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroid receptor concentration in breast carcinoma tissue: effect of devascularization during mastectomy.
    Leight GS; Wells SA; McCarty KS
    Surgery; 1984 Mar; 95(3):256-60. PubMed ID: 6701781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
    Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.